Cargando…
Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
INTRODUCTION: Cigarette smoking continues to be the leading cause of preventable death and is the main risk factor of major diseases such as chronic obstructive pulmonary disease (COPD). The best treatment to help smokers quit is a combination of behavioural support with pharmacotherapy. Varenicline...
Autores principales: | Kotz, Daniel, Simpson, Colin, Viechtbauer, Wolfgang, van Schayck, Onno C P, West, Robert, Sheikh, Aziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156814/ https://www.ncbi.nlm.nih.gov/pubmed/25168037 http://dx.doi.org/10.1136/bmjopen-2014-005281 |
Ejemplares similares
-
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study
por: Kotz, Daniel, et al.
Publicado: (2015) -
Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the “real world”
por: Kotz, Daniel, et al.
Publicado: (2014) -
The efficacy and safety of a nicotine conjugate vaccine (NicVAX(®)) or placebo co-administered with varenicline (Champix(®)) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial
por: Hoogsteder, Philippe HJ, et al.
Publicado: (2012) -
Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022) -
Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
por: Stapleton, John, et al.
Publicado: (2013)